VRCA

MKT CAP:$101M

Verrica Pharmaceuticals Inc

Market Cap

$101M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$5.66-$2.64 (-31.81%)

Jul 15, 2026

52W High $9.1052W Low $3.28

Company Details

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-dev...

Leadership

Jayson M. Rieger M.B.A., Ph.D.

President, CEO & Director

John J. Kirby CPA

Interim Chief Financial Officer

Noah L. Rosenberg M.D.

Chief Medical Officer

David Zawitz

COO, Chief Legal Officer & Secretary

Eugene Scavola

Executive Vice President of Technical Operations

Bradley J. Catalone MBA, Ph.D.

Head of Drug Development

Chris Chapman

Chief Commercial Officer

IPO Date

Jun 15, 2018

Website

www.verrica.com

Key Metrics TTM

Revenue

$37M

+417.6% YoY

Net Income

-$18M

EPS (Diluted)

Free Cash Flow

-$14M

Revenue / Share

$3.49

Gross Margin

89.5%

Operating Margin

-36.4%

Net Margin

-48.0%

FCF Margin

-38.0%

P/S

2.7x

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue by Product

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee